[1]
Pompilio, G. and Integlia, D. 2022. Cost per responder for methotrexate versus other therapies in patients with moderate-to-severe plaque psoriasis in Italy. Global and Regional Health Technology Assessment. 9, 1 (Nov. 2022), 138–145. DOI:https://doi.org/10.33393/grhta.2022.2474.